97-1751. Drexel Chemical Company; Pesticide Tolerance Petition Filing  

  • [Federal Register Volume 62, Number 16 (Friday, January 24, 1997)]
    [Notices]
    [Pages 3685-3688]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-1751]
    
    
    -----------------------------------------------------------------------
    
    ENVIRONMENTAL PROTECTION AGENCY
    [PF-693; FRL-5583-8]
    
    
    Drexel Chemical Company; Pesticide Tolerance Petition Filing
    
    AGENCY: Environmental Protection Agency (EPA).
    
    ACTION: Notice of filing.
    
    -----------------------------------------------------------------------
    
    SUMMARY: This notice is a summary of a pesticide petition proposing the 
    establishment of a tolerance for residues of diuron in or on the edible 
    portions of catfish. The summary was prepared by the petitioner, Drexel 
    Chemical Company.
    
    DATES: Comments, identified by the docket number [PF-693], must be 
    received on or before, February 24, 1997.
    
    ADDRESSES: By mail, submit written comments to Public Response and 
    Program Resources Branch, Field Operations Division (7506C), Office of 
    Pesticide Programs, Environmental Protection Agency, 401 M St., SW., 
    Washington, DC 20460. In person, bring comments to Rm. 1132, CM#2, 1921 
    Jefferson Davis Highway, Arlington, VA.
        Comments and data may also be submitted electronically by sending 
    electronic mail (e-mail) to: opp-docket@epamail.epa.gov. Electronic 
    comments should be submitted as an ASCII file avoiding the use of 
    special characters and any form of encryption. Comments and data will 
    also be accepted on disks in WordPerfect in 5.1 file format or ASCII 
    file format. All comments and data in electronic form must be 
    identified by docket number [PF-693]. Electronic comments on this 
    proposed rule may be filed online at many Federal Depositary Libraries. 
    Additional information on electronic submissions may be found below in 
    this document.
        Information submitted as a comment concerning this document may be 
    claimed confidential by marking any part or all of that information as 
    ``Confidential Business Information'' (CBI). CBI should not be 
    submitted through e-mail. Information marked as CBI will not be 
    disclosed except in accordance with procedures set forth in 40 CFR part 
    2. A copy of the comment that does not contain CBI must be submitted 
    for inclusion in the public record. Information not marked confidential 
    may be disclosed publicly by EPA without prior notice. All written 
    comments will be available for public inspection in Rm. 1132 at the 
    address given above, from 8:30 a.m. to 4 p.m., Monday through Friday, 
    excluding legal holidays.
    
    FOR FURTHER INFORMATION CONTACT: Phillip V. Errico, Product Manager 
    (PM) 25, Registration Division (7505C), Office of Pesticide Programs, 
    Environmental Protection Agency, 401 M St., SW., Washington, DC 20460. 
    Office location, telephone number, and e-mail address: Rm. 245, CM#2, 
    1921 Jefferson Davis Highway, Arlington, VA, (703) 305-6027; e-mail: 
    errico.phillip@epamail.epa.gov.
    
    SUPPLEMENTARY INFORMATION: EPA has received pesticide petition (PP) 
    6F4680 from Drexel Chemical Company, POB 13327, Memphis, TN 38133-0237, 
    proposing to amend 40 CFR 180.106 by establishing a tolerance for 
    residues of the herbicide diuron [3-(3,4-dichlorophenyl)-1,1-
    dimethylurea] in or on the raw agricultural commodity catfish at 1 part 
    per million (ppm). The proposed analytical method is gas chromatography 
    (GC) with a nitrogen-phosphorous detector.
        Pursuant to section 408(d)(A)(i) of the Federal Food, Drug, and 
    Cosmetic Act (FFDCA), 21 U.S.C. 346a(e), as amended, Drexel Chemical 
    Company has submitted the following summary of information, data and 
    arguments in support of their pesticide petition. The summary was 
    prepared by Drexel Chemical Company and EPA has not fully evaluated the 
    merits of the petition. EPA edited the summary to clarify that the 
    conclusions and arguments were the petitioner's and not
    
    [[Page 3686]]
    
    necessarily EPA's and to remove certain extraneous material.
    
    I. Petition Summary
    
    A. Residue Chemistry
    
        1. Analytical method. An analytical method is available, a modified 
    form of DuPont Agricultural Products method #5470. The principle of the 
    determination is the hydrolysis of diuron and its metabolites by 
    alkaline reflux to 3,4-dichloroanaline (3,4-DCA), followed by a 
    distillation of the aniline into an acid solution. The acid distillate 
    is made alkaline with concentrated base and subsequently extracted into 
    an organic solvent (hexane) and analyzed by gas chromatography. With 
    the modified method, recoveries exceeded 70% and the limit of 
    quantitation (LOQ) is 0.01 g/g.
        2. Magnitude of the residues. Residue trials were conducted in 
    contained catfish ponds on a 30, 60 and 90-day treatment schedule. In 
    the 30-day treatment schedule pond, diuron residues in catfish fillet 
    were between 0.8 and 0.9 ppm after the first week post treatment, and 
    declined to 0.2 ppm after 8 weeks post treatment. Due to mortality from 
    Proliferative Gill Disease (PGD), no catfish were available after the 
    last treatment day for residue determination from the 60-day treatment 
    schedule pond. Diuron residues in catfish fillet from the 90-day 
    treatment schedule pond were 1.2 ppm on the last treatment day, rose 
    slightly to 1.4 ppm by day 7 post treatment, and declined to 1.1 ppm by 
    day 28 post treatment.
        Using data from the magnitude of the residue study, a 
    pharmacokinetic model was developed that allowed the prediction of 
    diuron residues in catfish fillet using a treatment schedule of 
    applying 0.01 ppm diuron to the pond every 7 days for 56 days. Based on 
    the model, the maximum mean fillet residue from this treatment schedule 
    is predicted to be 0.75 ppm.
        The pharmacokinetic model was validated using data from an efficacy 
    study. Catfish were grown in ponds treated with 0.01 ppm diuron every 7 
    days. Diuron residues in catfish fillet were determined after 113 days 
    of treatment. The analysis found mean fillet residues of 0.92 ppm. The 
    pharmacokinetic model predicted day 113 diuron residues in catfish 
    fillet of 0.89 ppm. This excellent agreement between prediction and 
    found values demonstrates the utility of the model.
    
    B. Toxicological Profile
    
        1. Acute toxicity. The rat acute oral single dose LD50 is 3.5 
    g/kg. The rabbit acute dermal single dose LD50 is greater than 2 
    g/kg of bodyweight. The rat acute inhalation LD50 is less than 2.5 
    mg per liter. A primary eye irritation study in the rabbit shows that 
    diuron is moderately irritating to the unwashed eye when instilled 
    undiluted. A primary dermal irritation showed that diuron is not a skin 
    irritant when applied undiluted. A skin sensitization study (Buehler) 
    in the guinea pig shows that diuron is not a skin sensitizer when 
    applied undiluted.
        2. Genotoxicity. In the CHO/HGBRT assay the results for diuron are 
    negative up to cytotoxic levels in the presence of S9 activation (0.75 
    mm) and in the absence of S9 metabolic activation (1.25 mm).
        For the in vivo cytogenic study in rats, diuron is clastogenic at 
    5,000 mg/kg, the highest dose level tested.
        For the in vitro unscheduled DNA synthesis assay in primary rat 
    hepatocytes, diuron is negative up to 20 mm, the highest concentration 
    tested.
        Diuron was not considered to be mutagenic to TA97, TA98, TA100 and 
    TA1535 strains of Salmonella typhimurium (Ames Salmonella plate assay) 
    either with or without metabolic activation at the concentrations 
    tested (-S9, 0.5, 1, 2.5, 5 and 10 g/plate; S9, 10, 25, 100 
    and 250 g/plate).
        3. Developmental and reproductive toxicity. In a reproductive 
    toxicity study in the rat, the no-observed effect level/lowest observed 
    effect level (NOEL/LOEL) for parental/offspring systemic toxicity and 
    developmental toxicity were determined to be 250 and 1,750 ppm (16.9 
    and 120 mg/kg/day for males and 20.3 and 144 mg/kg/day for females), 
    respectively, based on decreased body weight gain and food consumption 
    in both sexes and generations. There was no evidence that diuron 
    affected reproductive performance in the rat.
        In a developmental toxicity study in the rat, the maternal toxicity 
    NOEL/LOEL were considered to be 16 and 80 mg/kg/day, respectively, 
    based on reduction in body weight and food consumption. The 
    developmental toxicity NOEL/LOEL were considered to be 80 and 400 mg/
    kg/day, respectively, based on statistically significant increases in 
    delayed ossification of the vertebrae and sternebrae and decreased 
    fetal weights.
        In a developmental toxicity study in rabbits, the NOEL/LOEL 
    maternal toxicity were considered to be 10 and 50 mg/kg/day, 
    respectively, based on decreased body weight and food consumption. 
    There was no evidence of developmental effects in the study.
        4. Subchronic toxicity. In a non-guideline subchronic (6-month) 
    oral toxicity study in rats, the systemic NOEL of technical diuron was 
    sought. The scope of the study was primarily restricted to parameters 
    affecting the erythrocytes. Based on the study findings, the systemic 
    NOEL of diuron could not be determined, since some findings were judged 
    to be equivocal.
        5. Chronic toxicity/oncogenicity. The chronic rat oral toxicity 
    study was acceptable as supplementary data. However, deficiencies exist 
    in the study because several organs were not examined, such as the 
    mammary glands. No NOEL was determined. The LOEL was considered to be 
    25 ppm (1.02 and 1.69 mg/kg/day for males and females, respectively), 
    the lowest dose level tested in this study based on increased 
    erythrocyte count in females, increased hemosiderin in the spleen, 
    increased spleen weight, bone marrow activation, increased 
    hematopoietic marrow, decreased fat marrow, and thickened urinary 
    bladder wall in males.
        The chronic oral toxicity study in dogs was acceptable. The NOEL/
    LOEL in the study were considered to be 25 and 125 ppm (1.88 and 9.33 
    mg/kg/day, respectively, for both males and females) based on abnormal 
    blood pigments in the blood.
        The oncogenicity phase of the combined chronic toxicity/
    oncogenicity study in rats was considered to be supplementary. However, 
    deficiencies exist in the study because several organs were not 
    examined, such as the mammary glands.
        The oncogenicity study in mice was considered to be acceptable. The 
    NOEL/LOEL for systemic toxicity were considered to be 250 ppm (50.8 and 
    77.5 mg/kg/day for males and females, respectively) based on decreased 
    body weight gain, and increased spleen and liver weight in males, 
    elevated leucocyte and reticulocyte counts, mean corpuscular volume and 
    mean corpuscular hemoglobin, and bilirubin values in both sexes; 
    increased incidence of intracellular pigments in renal tubules in 
    females and in the spleen of males and females; increased incidence of 
    hemosiderin deposits in liver cells in males; increased incidence of 
    liver single cell necrosis and cell mitosis in both sexes; increased 
    incidence of enlarged degenerative cells in females and of hepatopathy 
    and Kupffer cells in males; increased incidence of urinary bladder 
    edema and epithelial hyperplasia, thickened mucosa and enlarged uterine 
    horn in females. In the study, a statistically significant increase 
    (14%,  0.01) of ovarian luteoma was noted in mice of the 
    2,500 ppm group as compared to the concurrent controls (6%). This value
    
    [[Page 3687]]
    
    was higher than the historical control incidence of 1.7% for ovarian 
    luteoma tumor. Combined ovarian sex cord tumors were also increased. 
    Mammary gland tumors (adenocarcinoma type A and B) in the 2,500 ppm 
    group were statistically significantly higher than the concurrent 
    control (12%, p  0.05 vs. 4% in the concurrent control) and 
    higher than the historical control of 3.3%.
    
    C. Aggregate Exposure
    
        1. Dietary exposure.--a. Food. A Registration Eligibility Document 
    (RED) for diuron is not scheduled for completion until outstanding data 
    requirements requested by the EPA's Office of Pesticide Programs 
    Environmental Fate and Effects Division are completed. Therefore, a 
    dietary exposure assessment using anticipated residues is not 
    available. In the absence of a dietary exposure assessment, the 
    petitioners conducted a very conservative exposure assessment with 
    proposed tolerance level residues (maximum residues permitted) for all 
    crops for which the technical registrants intend to provide supporting 
    data. The food, ``freshwater finfish'' was included with an anticipated 
    residue level of 0.75 ppm, to represent catfish consumption.
        Since freshwater finfish can come from a number of sources, 
    including sport fishing, commercial catch, and aquaculture, and could 
    be other popular finfish species, such as trout or tilapia, the 
    consumption estimate is extremely conservative. In addition, diuron is 
    applied to contained ponds used in commercial catfish production during 
    a 2 to 4-month period in the summer and fall. However, the fish are 
    harvested from the ponds the year round. Residue estimates for other 
    foods were adjusted to reflect the percent of crop treated, based on 
    USDA data.
        Exposure estimates were compared to a Reference Dose (RfD) of 0.003 
    mg/kg bwt/day (mkd), which was recommended by the RfD Review Committee 
    at their September 26, 1996, meeting.
        The maximum total exposure to the U. S. population for all uses of 
    diuron, including the use in catfish ponds, is 0.000593 mkd, which 
    represents 19.8% of the RfD. The most highly exposed subgroup of the U. 
    S. population was non-hispanic other than black or white (e.g., 
    asians), which had a total exposure of 0.000787 mkd, representing 26.6% 
    of the RfD.
        Exposure to all infants was 0.001537 mkd (51.2% of the RfD), and 
    exposure to non-nursing infants less than a year old was 0.000675 mkd 
    (63.3% of the RfD). Exposure to children from 1 to 6 years old was 
    0.001386 (46.2% of the RfD), and exposure to children 7 to 12 years old 
    was 0.000795 mkd (26.5% of the RfD). Exposure to females of 
    childbearing age (13 to 50 years of age) was 0.000435 mkd (14.5% of the 
    RfD).
        b. Drinking water. Data concerning potential exposure through 
    drinking water is not available. The proposed use in catfish ponds is 
    not expected to add potential exposure to drinking water. Contained 
    catfish ponds are drained for levee repair every 5 to 10 years. The 
    water is returned to the pond to the greatest extent possible after the 
    repair. In some cases, the water may be released to a ditch or a 
    stream. Because market catfish are harvested from the ponds year round 
    as the catfish in a pond reach marketable size, the repair work is not 
    seasonal, but completed on a staggered basis, and does not necessarily 
    occur during the time of year when diuron may be applied to the pond 
    waters. Diuron is moderately toxic, there have been detections in 
    groundwater, and it has low to intermediate mobility in fine to coarse 
    textured soils and freshwater sediment (according to the Diuron 
    Environmental Fate Profile completed for the U.S. EPA by Dynamac, dated 
    June 10, 1982, pp 37-49). Based on these three factors, a conservative 
    10% of exposure has been reserved for drinking water.
        2. Non-dietary exposure. Diuron is not expected to be used in 
    residential settings. However, some registered product labels include 
    uses, while not intended for residential use, could conceivably result 
    in residential exposure. These uses include application to ornamentals, 
    use as a wood preservative (algicide in boat paints), or application to 
    turf. A conservative 5% of the total exposure has been reserved to 
    account for the uses which could potentially result in residential or 
    lawn use.
    
    D. Cumulative Effects
    
        Linuron is the only chemical, registered in the United States as a 
    pesticide, which is chemically similar to diuron. Despite the 
    structural similarity, based on publicly available information, some of 
    their toxicological activities differ significantly. In the 
    carcinogenicity studies, mice treated with 2,500 ppm diuron developed 
    mammary adenocarcinomas and ovarian luteomas. Rats treated with 2,500 
    ppm diuron developed urinary bladder carcinomas. Mammary glands were 
    not evaluated in this study. For linuron, mice in the carcinogenicity 
    study developed hepatocellular adenomas. Rats developed testicular 
    carcinomas which were not hormone dependant. The carcinogen 
    classification of diuron is currently under review. Linuron is 
    considered a Group C carcinogen (without Q*) Non-tumor lesions in rats 
    administered diuron included anemia and an increased reticulocyte 
    count. In the chronic linuron study, there was a decrease in the 
    reticulocyte count.
        Based on these considerations, there is insufficient evidence to 
    determine if cumulative toxicity will occur.
    
    E. Safety Determination
    
        1. U. S. population. Maximum exposure to the U. S. population 
    resulting from the use of diuron, including the use in catfish ponds, 
    is not expected to exceed 0.000593 mkd, representing 19.8% of the RfD. 
    After adding 10% for potential drinking water and 5% for potential 
    residential/lawn exposure, the total exposure represents only 34.8% of 
    the RfD. Therefore, there is a reasonable certainty of no harm 
    resulting from aggregate exposure of diuron to the general population.
        2. Infants and children. Maximum exposure to the most highly 
    exposed infants and children subgroup, non-nursing infants less than a 
    year old, is not expected to exceed 0.001900 mkd, which represents 
    63.3% of the RfD. After adding 10% for potential drinking water 
    exposure, and 5% for potential residential/lawn exposure, the total 
    exposure to this subgroup represents only 78.3% of the RfD. Therefore, 
    there is a reasonable certainty of no harm resulting from aggregate 
    exposure of diuron to infants and children.
        These results represent very conservative consumption and residue 
    levels. An exposure estimate based on anticipated residues for all 
    foods, and consumption of farm-raised catfish only, would result in a 
    greatly diminished risk.
    
    F. International Tolerances
    
        A maximum residue level has not been established for diuron by the 
    Codex Alimentarius Commission.
    
    II. Public Record
    
        Interested persons are invited to submit comments on this notice of 
    filing. Comments must bear a notation indicating the docket control 
    number, [PF-693].
        A record has been established for this notice of filing under 
    docket control number [PF-693] (including comments and data submitted 
    electronically as described below). A public version of this record, 
    including printed, paper versions of electronic comments, which does 
    not include any information claimed as CBI, is available for inspection 
    from 8:30 a.m. to 4 p.m.,
    
    [[Page 3688]]
    
    Monday through Friday, excluding legal holidays. The public record is 
    located in Rm. 1132 of the Public Response and Program Resources 
    Branch, Field Operations Division (7506C), Office of Pesticide 
    Programs, Environmental Protection Agency, Crystal Mall #2, 1921 
    Jefferson Davis Highway, Arlington, VA.
        Electronic comments may be sent directly to EPA at:
        opp-docket@epamail.epa.gov.
    
    
        Electronic comments must be submitted as an ASCII file avoiding the 
    use of special characters and any form of encryption.
        The official record for this notice, as well as the public version, 
    as described above, will be kept in paper form. Accordingly, EPA will 
    transfer all comments received electronically to printed, paper form as 
    they are received and will place the paper copies in the official 
    notice record which will also include all comments submitted directly 
    in writing. The official rulemaking record is the paper record 
    maintained at the address in ``ADDRESSES'' at the beginning of this 
    document.
    
    List of Subjects
    
        Environmental protection, Administrative practice and procedure, 
    Agricultural commodities, Pesticides and pests, Reporting and 
    recordkeeping requirements.
    
        Dated: January 16, 1997.
    
    Stephen L. Johnson,
    
    Director, Registration Division, Office of Pesticide Programs.
    
    [FR Doc. 97-1751 Filed 1-23-97; 8:45 am]
    BILLING CODE 6560-50-F
    
    
    

Document Information

Published:
01/24/1997
Department:
Environmental Protection Agency
Entry Type:
Notice
Action:
Notice of filing.
Document Number:
97-1751
Dates:
Comments, identified by the docket number [PF-693], must be received on or before, February 24, 1997.
Pages:
3685-3688 (4 pages)
Docket Numbers:
PF-693, FRL-5583-8
PDF File:
97-1751.pdf